The Lynx Group
Association for Value-Based Care

Changes in Cancer Care



Gary Palmer, MD, JD, MBA, MPH points out how a better overall understanding of genomics and the immune system have had in developing oncology therapies.

Related Articles

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to recieve the free VBCC print publication or weekly e‑Newsletter.

I'd like to recieve: